Balance Sheet :: BioSig Technologies, Inc. (BSGM)

v3.24.2.u1

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 2,104	$ 190
Accounts receivable	54	24
Employee advance		5
Net investment in leases, short term	65	103
Prepaid expenses and vendor deposits	163	206
Total current assets	2,386	528
Property and equipment, net	137	509
Right-to-use assets, net	257	412
Other assets:
Net investment in leases, long term	4	17
Patents, net	279	288
Other assets	44	44
Total assets	3,107	1,798
Current liabilities:
Accounts payable and accrued expenses, including $15 and $30 to related parties as of June 30, 2024 and December 31, 2023, respectively	2,604	4,116
Customer deposits		16
Dividends payable	105	101
Lease liability, short term	267	349
Total current liabilities	2,976	4,582
Long term liabilities:
Lease liability, long term	15	103
Total long term liabilities	15	103
Total liabilities	2,991	4,685
Commitments and contingencies (Note 12)
Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; liquidation preference of $105 as of June 30, 2024 and December 31, 2023	105	105
Deficit
Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock. 105 shares of Series C outstanding as of June 30, 2024 and December 31, 2023 (see above)
Common stock, $0.001 par value, authorized 200,000,000 shares, 15,110,846 and 9,040,043 issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	15	9
Additional paid in capital	252,311	241,988
Accumulated deficit	(252,332)	(245,015)
Total stockholders’ deficit attributable to BioSig Technologies, Inc.	(6)	(3,018)
Non-controlling interest	17	26
Total equity (deficit)	11	(2,992)
Total liabilities and equity (deficit)	$ 3,107	$ 1,798

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Balance Sheet

Source